Synthetic mycobacterial molecular patterns partially complete Freund’s adjuvant

Jean-Yves Dubé , Fiona Mcintosh , Juan G Zarruk , Samuel David , Jérôme Nigou (1) , Marcel A Behr (2)

1 IPBS - Institut de pharmacologie et de biologie structurale
2 Department of Microbiology and Immunology, McGill University, Montréal, Canada

Complete Freund's adjuvant (CFA) has historically been one of the most useful tools of immunologists. Essentially comprised of dead mycobacteria and mineral oil, we asked ourselves what is special about the mycobacterial part of this adjuvant, and could it be recapitulated synthetically? Here, we demonstrate the essentiality of N-glycolylated peptidoglycan plus trehalose dimycolate (both unique in mycobacteria) for the complete adjuvant effect using knockouts and chemical complementation. A combination of synthetic N-glycolyl muramyl dipeptide and minimal trehalose dimycolate motif GlcC14C18 was able to upregulate dendritic cell effectors, plus induce experimental autoimmunity qualitatively similar but quantitatively milder compared to CFA. This research outlines how to substitute CFA with a consistent, molecularly-defined adjuvant which may inform the design of immunotherapeutic agents and vaccines benefitting from cell-mediated immunity. We also anticipate using synthetic microbe-associated molecular patterns (MAMps) to study mycobacterial immunity and immunopathogenesis.

Domains: Life Sciences [q-bio]

Jean-Yves Dubé, Fiona Mcintosh, Juan G Zarruk, Samuel David, Jérôme Nigou, et al.. Synthetic mycobacterial molecular patterns partially complete Freund’s adjuvant. Scientific Reports, 2020, 10 (1), pp.5874. ⟨10.1038/s41598-020-62543-5⟩. ⟨hal-03031804⟩